Ulcerative colitis: from molecular pathophysiology to management and the emerging role of natural and pharmacological drug candidates.

Sharata EE, Bakry T, Mohamed H, Mohyeldin RH, Rofaeil RR, Hemeida RAM, Kotb ASM, Abdelnaser M

Open source

DOI
10.1007/s00210-026-05574-5
Published
2026 Sep
Container
Naunyn-Schmiedeberg's archives of pharmacology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s00210-026-05574-5,
  title = {Ulcerative colitis: from molecular pathophysiology to management and the emerging role of natural and pharmacological drug candidates.},
  author = {Sharata EE and Bakry T and Mohamed H and Mohyeldin RH and Rofaeil RR and Hemeida RAM and Kotb ASM and Abdelnaser M},
  year = {2026},
  journal = {Naunyn-Schmiedeberg's archives of pharmacology},
  doi = {10.1007/s00210-026-05574-5},
  url = {https://doi.org/10.1007/s00210-026-05574-5}
}

RIS

TY  - JOUR
TI  - Ulcerative colitis: from molecular pathophysiology to management and the emerging role of natural and pharmacological drug candidates.
AU  - Sharata EE
AU  - Bakry T
AU  - Mohamed H
AU  - Mohyeldin RH
AU  - Rofaeil RR
AU  - Hemeida RAM
AU  - Kotb ASM
AU  - Abdelnaser M
PY  - 2026
JO  - Naunyn-Schmiedeberg's archives of pharmacology
DO  - 10.1007/s00210-026-05574-5
UR  - https://doi.org/10.1007/s00210-026-05574-5
ER  - 

APA

EE, S., T, B., H, M., RH, M., RR, R., RAM, H., ASM, K., & M, A. (2026). Ulcerative colitis: from molecular pathophysiology to management and the emerging role of natural and pharmacological drug candidates.. Naunyn-Schmiedeberg's archives of pharmacology. https://doi.org/10.1007/s00210-026-05574-5

Source records